Case number 1:22-cv-00728
Vertex Pharmaceuticals Incorporated v. Aurobindo Pharma Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 10, 2022 | 20 | REDACTED VERSION of 16 Letter, by Vertex Pharmaceuticals Incorporated. (Fahnestock, Derek) Modified on 8/10/2022 (nms). (Entered: 08/10/2022) (1) |
| Aug 9, 2022 | 19 | NOTICE OF SERVICE of Initial Disclosures Under Federal Rule of Civil Procedure 26(a)(1) and Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Vertex Pharmaceuticals Incorporated.(Blumenfeld, Jack) (Entered: 08/09/2022) (3) |
| Jul 29, 2022 | N/A | Case Referred to Magistrate Judge (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke. (nms) |
| Jul 29, 2022 | 18 | Order (13) Docket Text: SO ORDERED Granting Proposed Order to Consolidate and Amend Scheduling Order filed (*Reset Deadlines: Amended Pleadings due by 1/6/2023, Fact Discovery completed by 3/31/2023, Joinder of Parties due by 1/6/2023, a 3 day Bench Trial is set to start 2/20/2024, at 8:30 AM in Courtroom 6A, a Pretrial Conference is set for 2/9/2024, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 7/29/2022. Associated Cases: 1:20-cv-00988-RGA-CJB, 1:22-cv-00728-RGA(nms) |
| Jul 28, 2022 | 17 | Proposed Order (13) Docket Text: PROPOSED ORDER to Consolidate and Amend Scheduling Order, by Vertex Pharmaceuticals Incorporated. (Fahnestock, Derek) Modified on 7/28/2022 (nms). |
| Jul 27, 2022 | 15 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Initial Disclosures Under Paragraph 4(c) of the District of Delaware Default Standard for Discovery filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) |
| Jun 30, 2022 | 14 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Production of Defendants' Core Technical Documents Pursuant to Paragraph 4(b) of the Delaware Default Standard for Discovery and Pursuant to the Standing Order Regarding Hatch-Waxman Cases in Which Infringement is Alleged filed by Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc..(Myer, R.) |
| Jun 29, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Timothy H. Kratz and Michael P. Hogan for Aurobindo Pharma Limited and Aurobindo Pharma U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Jun 27, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz, filed by Aurobindo Pharma U.S.A., Inc., Aurobindo Pharma Limited, and [13] MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan, filed by Aurobindo Pharma U.S.A., Inc., Aurobindo Pharma Limited. Signed by Judge Richard G. Andrews on 6/27/2022. (nms) |
| Jun 27, 2022 | 10 | Answer to Complaint (11) Docket Text: ANSWER to [1] Complaint, by Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc..(Myer, R.) |
| Jun 27, 2022 | 11 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Ltd. for Aurobindo Pharma U.S.A., Inc. filed by Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc.. (Myer, R.) |
| Jun 27, 2022 | 12 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz - filed by Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc.. (Myer, R.) |
| Jun 27, 2022 | 13 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan - filed by Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc.. (Myer, R.) |
| Jun 8, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Jun 7, 2022 | 9 | Affidavit of Service (10) Docket Text: AFFIDAVIT of Service for Summons, Complaint and Related Papers served on Aurobindo Pharma Limited on June 6, 2022, filed by Vertex Pharmaceuticals Incorporated. (Fahnestock, Derek) |
| Jun 6, 2022 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Vertex Pharmaceuticals Incorporated. Aurobindo Pharma U.S.A., Inc. served on 6/6/2022, answer due 6/27/2022. (Blumenfeld, Jack) |
| Jun 2, 2022 | 1 | Complaint (9) Docket Text: COMPLAINT filed against Aurobindo Pharma Limited and Aurobindo Pharma U.S.A., Inc. ( Filing fee $ 402, receipt number ADEDC-3887797.) - filed by Vertex Pharmaceuticals Incorporated. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(srs) (Additional attachment(s) added on 6/6/2022: # (1) Exhibit A, # (2) Civil Cover Sheet) (smg). |
| Jun 2, 2022 | 1 | Exhibit A (45) |
| Jun 2, 2022 | 1 | Civil Cover Sheet (1) |
| Jun 2, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (srs) |
| Jun 2, 2022 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: April 21, 2022. Date of Expiration of Patent: August 13, 2029.Thirty Month Stay Deadline: October 21, 2024. (srs) |
| Jun 2, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,646,481 B2. (srs) |
| Jun 2, 2022 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Vertex Pharmaceuticals Incorporated. (srs) |
| Jun 2, 2022 | 6 | Summons Issued (2) Docket Text: Summons Issued as to Aurobindo Pharma U.S.A., Inc. on 6/2/2022. (srs) |
| Jun 2, 2022 | 7 | Summons Issued (2) Docket Text: Summons Issued as to Aurobindo Pharma Limited on 6/2/2022. (srs) |
